miscsubjectsAI governance
Evidence review

TB-500 for Trigeminal Issues: Evidence-Graded Review of Repair Pathways

· · 3 min read
bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `tb-500-trigeminal`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/tb-500-trigeminal

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/tb-500-trigeminal/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/tb-500-trigeminal/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/tb-500-trigeminal/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/tb-500-trigeminal/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

*Not medical advice. Tier-honest. Cite claim/source ids.*

What's breaking down

The body is always doing two things at once: breaking down (degeneration) and building back (regeneration). A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal (pain, acid, anxiety, inflammation) without fixing the tissue that caused the signal. Peptides in this ledger are studied for repair pathways: new blood vessels, repair-cell migration, nerve regrowth, gut lining, neural connections. This article maps one compound through that frame — what it is, how it is proposed to work, what evidence exists, and what people report.

This topic: TB-500 (thymosin beta-4) is studied for repair-cell migration and actin regulation — cells that need to reach an injury and rebuild structure. That is regeneration: move repair machinery to the damage.

Why TB-500 might help you

  1. What keeps failing: Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.
  2. What TB-500 is studied to do: Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.
  3. Therefore for you: If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.

How these fit together

Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.

  • TB-500 → inflammation clearance / repair-cell migration

What the evidence actually shows

This is a count of what is in this ledger — not a claim about all research worldwide.

  • Scientific sources catalogued (PubMed, trials, reviews): 2
  • Claims tagged human evidence: 1
  • Claims tagged preclinical (animal/lab): 2
  • Claims tagged anecdotal: 1
  • Reddit posts catalogued: 2
  • X posts catalogued: 0
  • Other anecdote sources (YouTube, Instagram, etc.): 0
  • Total sources in chain: 5

Quantified confidence (this ledger): 0.27 / 1.00 — low — animal and anecdote heavy

Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.

What scientists say

Thymosin β4 Promotes the Recovery of Peripheral Neuropathy (source s5)

2012 mouse study on Tβ4 and diabetic neuropathy.

Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.

Neuroprotective and neurorestorative effects of Thymosin beta 4 treatment following experimental traumatic brain injury (source s25)

2012 rat TBI study results.

Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.

What people say on Reddit

Peptides?? — Reddit, r/Occipitalneuralgia (source s0)

Reddit discussion on peptides for neuralgia-like issues.

Peptide ARA-290 — Reddit, r/neuropathy (source s1)

User anecdote involving TB-500 in neuropathy protocol.

---

Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.

Explore this article's relationships

Trigeminal neuralgia · condition map

Connected articles

Where this sits in the evidence graph. Open the full interactive map for the whole neighborhood.

Full map →
RelatedTB-500: Thymosin Beta-4 · 14 humanAging Repair Stack: BPC-157 + TB-500 + GHK-Cu · 12 humanRecovery Stack for Complex Injuries: BPC-157 + TB-500 + ARA-290 · 7 humanTB-500 for Benzodiazepine Withdrawal: Evidence-Graded Review · 2 human
Evidence · 5 sources · swipe →chain cfe64a854b13 · verify chain · provenance
1 / 5
Evidence ledger 4 · tier-ranked · API
human
Clinical trials of thymosin beta-4 in neurotrophic keratopathy showed accelerated healing of corneal epithelial defects and potential nerve regeneration support.
sources: s7
preclinical
Rat TBI studies with Tβ4 at 6-30 mg/kg reduced lesion volume and improved functional outcomes.
sources: s25
preclinicallow confidence
In a 2012 mouse model of diabetic peripheral neuropathy, Tβ4 improved sciatic nerve conduction velocity.
sources: s5
anecdotallow confidence
Forum users report exploring TB-500 in neuropathy stacks for nerve-related symptoms.
sources: s0, s1
Model review1 contributions · 1 modelExpand the recursive review layer
1 / 1
grok/grok-4.3writer
redraft2026-06-29 23:28
TB-500 for Trigeminal Issues: Evidence-Graded Review of Repair Pathways · 4 claims · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: Write a data-first, evidence-graded article: TB 500 for Trigeminal
Slug: tb-500-trigeminal
Audience: readers researching peptide evidence for this specific condition or drug cross.
Rules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.

ENRICHMENT BRIEF (binding section logic — one ## per compound):
{"voice":"enrichment","article_shape":"single_focus","condition":null,"condition_key":null,"primary_peptide":null,"peptides_in_scope":[{"id":"tb-500","name":"TB-500"}],"drugs_in_scope":[],"weight_sensitive":false,"stimulant_context":false,"breaking_down":{"section_title":"What's breaking down","degenerative_why":[],"degenerative
it output
{
  "slug": "tb-500-trigeminal",
  "title": "TB-500 for Trigeminal Issues: Evidence-Graded Review of Repair Pathways",
  "body": "## What's breaking down\n\nTrigeminal nerve problems often involve layers of degeneration where repair lags behind ongoing stress or injury. One layer is inflammation that fails to clear properly, leaving the nerve environment hostile to recovery. Another is actin and cytoskeleton issues that hinder cells from migrating to the damage site. A third is stalled structural rebuilding, including potential effects on nerve support tissues like those in the cornea when trigeminal innervation is compromised. If repair-cell migration and inflammation resolution are impaired, the condition can persist even when pain signals are managed separately. TB-500 research targets the migration and clearance layer specifically.\n\n## Why TB-500 might help you\n\n1. **What keeps failing:** Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.\n2. **What TB-500 is studied to do:** Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.\n3. **Therefore for you:** If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.\n\nThe logic chain runs: impaired cell movement to the trigeminal area keeps inflamm
f2baeb53a85c29cb
Machine verification: /api/articles/tb-500-trigeminal/contributions

Related articles

Trigeminal neuralgia · condition map

Open evidence map →
Aging Repair Stack: BPC-157 + TB-500 + GHK-Cuaging-stack-introRecovery Stack for Complex Injuries: BPC-157 + TB-500 + ARA-290recovery-stack-introTB-500: Thymosin Beta-4tb-500TB-500 for Benzodiazepine Withdrawal: Evidence-Graded Reviewtb-500-benzo-withdrawalTB-500 and Benzodiazepines: Repair Pathways vs GABA Suppressiontb-500-benzodiazepinesTB-500 and Statin-Associated Cognitive Effects: Repair Pathways and Ev…tb-500-brain-fog
Ask this article · 8 suggested prompts
topology · JSON · question graph

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (human tier): "Clinical trials of thymosin beta-4 in neurotrophic keratopathy showed accelerated healing of corneal epithelial defects and potential nerve …"?
ask tb-500-trigeminal claim c1 · paste includes §SELF
What does the ledger say about this (preclinical tier): "Rat TBI studies with Tβ4 at 6-30 mg/kg reduced lesion volume and improved functional outcomes."?
ask tb-500-trigeminal claim c3 · paste includes §SELF
What does the ledger say about this (preclinical tier): "In a 2012 mouse model of diabetic peripheral neuropathy, Tβ4 improved sciatic nerve conduction velocity."?
ask tb-500-trigeminal claim c2 · paste includes §SELF
What does the ledger say about this (anecdotal tier): "Forum users report exploring TB-500 in neuropathy stacks for nerve-related symptoms."?
ask tb-500-trigeminal claim c4 · paste includes §SELF
Summarize this reddit report and how it should weigh: "Reddit discussion on peptides for neuralgia-like issues."
ask tb-500-trigeminal source s0 · paste includes §SELF
Summarize this reddit report and how it should weigh: "User anecdote involving TB-500 in neuropathy protocol."
ask tb-500-trigeminal source s1 · paste includes §SELF
For my medical situation, what can you answer from your catalogue about TB-500 for Trigeminal Issues: Evidence-Graded Review of Repair Pathways — and what would you need me to tell you first?
ask tb-500-trigeminal condition gaps · paste includes §SELF
What good and bad outcomes are documented for TB-500 for Trigeminal Issues: Evidence-Graded Review of Repair Pathways (studies vs anecdotes)?
ask tb-500-trigeminal good bad experiences · paste includes §SELF
Add your experience or question
Think this article is wrong?
Call bullshit on CharlieOS →
Loading more articles…